Literature DB >> 26324905

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.

Stanley B Prusiner1, Amanda L Woerman2, Daniel A Mordes3, Joel C Watts4, Ryan Rampersaud2, David B Berry2, Smita Patel2, Abby Oehler5, Jennifer K Lowe6, Stephanie N Kravitz6, Daniel H Geschwind7, David V Glidden8, Glenda M Halliday9, Lefkos T Middleton10, Steve M Gentleman11, Lea T Grinberg12, Kurt Giles4.   

Abstract

Prions are proteins that adopt alternative conformations that become self-propagating; the PrP(Sc) prion causes the rare human disorder Creutzfeldt-Jakob disease (CJD). We report here that multiple system atrophy (MSA) is caused by a different human prion composed of the α-synuclein protein. MSA is a slowly evolving disorder characterized by progressive loss of autonomic nervous system function and often signs of parkinsonism; the neuropathological hallmark of MSA is glial cytoplasmic inclusions consisting of filaments of α-synuclein. To determine whether human α-synuclein forms prions, we examined 14 human brain homogenates for transmission to cultured human embryonic kidney (HEK) cells expressing full-length, mutant human α-synuclein fused to yellow fluorescent protein (α-syn140*A53T-YFP) and TgM83(+/-) mice expressing α-synuclein (A53T). The TgM83(+/-) mice that were hemizygous for the mutant transgene did not develop spontaneous illness; in contrast, the TgM83(+/+) mice that were homozygous developed neurological dysfunction. Brain extracts from 14 MSA cases all transmitted neurodegeneration to TgM83(+/-) mice after incubation periods of ∼120 d, which was accompanied by deposition of α-synuclein within neuronal cell bodies and axons. All of the MSA extracts also induced aggregation of α-syn*A53T-YFP in cultured cells, whereas none of six Parkinson's disease (PD) extracts or a control sample did so. Our findings argue that MSA is caused by a unique strain of α-synuclein prions, which is different from the putative prions causing PD and from those causing spontaneous neurodegeneration in TgM83(+/+) mice. Remarkably, α-synuclein is the first new human prion to be identified, to our knowledge, since the discovery a half century ago that CJD was transmissible.

Entities:  

Keywords:  Parkinson's disease; neurodegeneration; strains; synucleinopathies

Mesh:

Substances:

Year:  2015        PMID: 26324905      PMCID: PMC4586853          DOI: 10.1073/pnas.1514475112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.

Authors:  G C Telling; T Haga; M Torchia; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

2.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson's disease.

Authors:  C J Gibbs; D C Gajdusek
Journal:  Adv Neurol       Date:  1982

6.  Linkage of prion protein and scrapie incubation time genes.

Authors:  G A Carlson; D T Kingsbury; P A Goodman; S Coleman; S T Marshall; S DeArmond; D Westaway; S B Prusiner
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

7.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

8.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.

Authors:  G C Telling; M Scott; J Mastrianni; R Gabizon; M Torchia; F E Cohen; S J DeArmond; S B Prusiner
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

9.  Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Sooyeon Lee; Robert W Regenhardt; Nicholas H McGarvey; Jacob I Ayers; Lucia Notterpek; David R Borchelt; Todd E Golde; Benoit I Giasson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

10.  Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery.

Authors:  C J Gibbs; D M Asher; A Kobrine; H L Amyx; M P Sulima; D C Gajdusek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

View more
  292 in total

1.  Expanding the prion disease repertoire.

Authors:  Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-01       Impact factor: 11.205

Review 2.  Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Authors:  Trevor Tyson; Jennifer A Steiner; Patrik Brundin
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

3.  Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.

Authors:  Wolfgang Singer; Ann M Schmeichel; Mohammad Shahnawaz; James D Schmelzer; Bradley F Boeve; David M Sletten; Tonette L Gehrking; Jade A Gehrking; Anita D Olson; Rodolfo Savica; Mariana D Suarez; Claudio Soto; Phillip A Low
Journal:  Ann Neurol       Date:  2020-08-01       Impact factor: 10.422

4.  Towards authentic transgenic mouse models of heritable PrP prion diseases.

Authors:  Joel C Watts; Kurt Giles; Matthew E C Bourkas; Smita Patel; Abby Oehler; Marta Gavidia; Sumita Bhardwaj; Joanne Lee; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2016-06-28       Impact factor: 17.088

Review 5.  Neurodegenerative Disease Transmission and Transgenesis in Mice.

Authors:  Brittany N Dugger; Daniel P Perl; George A Carlson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

6.  Sensitivity and specificity of phospho-Ser129 α-synuclein monoclonal antibodies.

Authors:  Vedad Delic; Sidhanth Chandra; Hisham Abdelmotilib; Tyler Maltbie; Shijie Wang; Danielle Kem; Hunter J Scott; Rachel N Underwood; Zhiyong Liu; Laura A Volpicelli-Daley; Andrew B West
Journal:  J Comp Neurol       Date:  2018-08-15       Impact factor: 3.215

Review 7.  Genetics of Synucleinopathies.

Authors:  Robert L Nussbaum
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

8.  The effect of truncation on prion-like properties of α-synuclein.

Authors:  Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

9.  Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.

Authors:  Kun Zhao; Yeh-Jun Lim; Zhenying Liu; Houfang Long; Yunpeng Sun; Jin-Jian Hu; Chunyu Zhao; Youqi Tao; Xing Zhang; Dan Li; Yan-Mei Li; Cong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-31       Impact factor: 11.205

10.  Propagation of prions causing synucleinopathies in cultured cells.

Authors:  Amanda L Woerman; Jan Stöhr; Atsushi Aoyagi; Ryan Rampersaud; Zuzana Krejciova; Joel C Watts; Takao Ohyama; Smita Patel; Kartika Widjaja; Abby Oehler; David W Sanders; Marc I Diamond; William W Seeley; Lefkos T Middleton; Steve M Gentleman; Daniel A Mordes; Thomas C Südhof; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.